Concepedia

Marco Vignetti

MV

Statistics

Publications

146

Citations

13.9K

H-Index

56

Active since

1989

Affiliations

Sapienza University of Rome(Current)

Fondazione Gimema Onlus

University of Bologna

University of Rome Tor Vergata

Istituti di Ricovero e Cura a Carattere Scientifico

Marco Vignetti is an author at Sapienza University of Rome specializing in oncology, medicine, and hematologic malignancy therapy.

ORCID

Publications per year

1989–2024

146

Publications

146

Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

Brunangelo Falini, Cristina Mecucci, Enrico Tiacci et al. · New England Journal of Medicine · 2005 · 1.9K citations · Full text

, , +14

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

, , +17

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foà, Renato Bassan, Antonella Vitale et al. · New England Journal of Medicine · 2020 · 499 citations · Full text

, , +12

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Robin Foà, Antonella Vitale, Marco Vignetti et al. · Blood · 2011 · 461 citations · Full text

, , +12

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

Uwe Platzbecker, Giuseppe Avvisati, Laura Cicconi et al. · Journal of Clinical Oncology · 2016 · 392 citations · Full text

, , +12

1–5 of 146